Citadel Advisors
DRIO icon

Citadel Advisors’s DarioHealth DRIO Stock Holding History

Citadel Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,050
Closed -$108K – 13022
2025
Q2 		$108K Buy
8,050
+2,850
+55% +$39.5K ﹤0.01% 11279
2025
Q1 		$63.7K Sell
5,200
-760
-13% -$10.7K ﹤0.01% 12037
2024
Q4 		$93.7K Buy
5,960
+745
+14% +$12.9K ﹤0.01% 11572
2024
Q3 		$117K Buy
5,215
+3,400
+187% +$68.9K ﹤0.01% 10916
2024
Q2 		$43.2K Buy
1,815
+140
+8% +$3.97K ﹤0.01% 11929
2024
Q1 		$51.3K Buy
1,675
+1,605
+2,293% +$60.9K ﹤0.01% 12154
2023
Q4 		$2.41K Sell
70
-265
-79% -$9.44K ﹤0.01% 13703
2023
Q3 		$22K Sell
335
-265
-44% -$17.9K ﹤0.01% 12554
2023
Q2 		$48.1K Buy
600
+495
+471% +$37.6K ﹤0.01% 11844
2023
Q1 		$8.65K Sell
105
-3,430
-97% -$337K ﹤0.01% 13644
2022
Q4 		$303K Sell
3,535
-1,580
-31% -$142K ﹤0.01% 9304
2022
Q3 		$474K Buy
5,115
+4,060
+385% +$436K ﹤0.01% 8571
2022
Q2 		$130K Sell
1,055
-70
-6% -$8.21K ﹤0.01% 11131
2022
Q1 		$131K Sell
1,125
-1,640
-59% -$271K ﹤0.01% 12001
2021
Q4 		$717K Buy
2,765
+2,220
+407% +$675K ﹤0.01% 8773
2021
Q3 		$149K Sell
545
-910
-63% -$263K ﹤0.01% 12389
2021
Q2 		$622K Buy
+1,455
New +$554K ﹤0.01% 9528

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's DRIO Position: Q1 2026 in Review

Citadel Advisors opened a new position in DarioHealth (DRIO) in Q1 2026: 20,460 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #11607 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in DRIO as recently as Q4 2024.

Citadel Advisors first reported a position in DRIO in Q2 2018 and has held it in 21 quarters since. The position peaked at $895K in Q2 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Citadel Advisors held 20,460 shares of DarioHealth worth $164K as of Q1 2026.
  • DarioHealth was a new Citadel Advisors position in Q1 2026.
  • DarioHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11607 holding.
  • Citadel Advisors first reported a position in DarioHealth in Q2 2018 and has held it in 21 quarters since.
  • Citadel Advisors's DarioHealth position peaked at $895K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.